retatrutide glucagon receptor agonist vs semaglutide: complete comparison of weight loss, mechanisms, and results Reta (RUO) | GIP/GLP-1/GCG Agonist

Do not administer more than 1 tablet per day

Molecular pathways documented in preclinical research include: (1) activation of nitric oxide (NO) synthesis via L-arginine/eNOS pathway, (2) transcriptional upregulation of VEGF-A and FGF-2 favouring angiogenesis, (3) modulation of the Egr-1 early transcription factor involved in fibroblast proliferation, (4) interaction with 5-HT2A and dopaminergic receptors in some behavioural models, (5) stabilisation of endothelial function via eNOS modulation and reduction of oxidative stress (8-OH-dG, MDA)

Use immediately after reconstitution or aliquot and store at -20C

Mood and anxiety ups and downs: These emotional shifts can make it harder to stick to healthy routines